American Oncology Network

Brian P. Mulherin, MD, shares his key takeaways from the 2025 ASCO Annual Meeting, highlighting significant advancements in SCLC and the challenge of information overload at large conferences.

William “Bill” J. Valle joins AON’s Board of Directors.

The AON Central Lab is recognized as the first laboratory in the world to use this technology, which decreases analysis time.

The Foundation, a non-profit of the American Oncology Network, provides grants for essential non-medical expenses to cancer patients in need.

Central Georgia Cancer Care is excited to announce their partnership with the American Oncology Network.

Woodlands Cancer Institute opens three clinic locations that provide medical oncology, radiation oncology and hematology care to its patients.

Alti Rahman and Susan Sabo-Wagner were selected as panelists at the Association of Cancer Care Centers event in Washington, D.C.

The community oncology practice is equipped to treat a wide variety of cancer types and is open to both new and current patients.

Bay Hematology Oncology joins the American Oncology Network.

The network’s physicians’ research reports were selected after a thorough peer review process.

Brooke Peters, PharmD, BCOP, offers a closing reflection on the transition from inpatient to outpatient treatment of bispecific antibodies.

A discussion on the evolving practices for administering bispecific T-cell engagers, from academic to community centers.

Dr. Peters shares clinical considerations for administering bispecifics, emphasizing the identification and mitigation strategies of late adverse events.

Expert regional community oncologist examines the grading and management of early adverse events such as CRS and ICANS, discussing the national guidelines that are utilized.

Expanding on the roles and responsibilities for executing a bispecifics administration program, highlighting a multidisciplinary collaboration to establish SOPs, training, and education.

Dr. Peters shares her experience in SOPs and program development for administration of bispecific T-cell engagers, noting program champions and key program components.

Brooke Peters, PharmD, BCOP, provides a comprehensive overview of her institution’s bispecifics administration program, highlighting several agents and the hematologic/oncologic conditions they treat.

AON’s specialty pharmacy reports success in reducing drug waste like unnecessary and early prescription refills.

American Oncology Cares Foundation and fund provide non-medical financial assistance to adult cancer patients.

Members of AON’s leadership team will speak and moderate several panel sessions at the Summit.

The conference brings together healthcare and community oncology leaders for clinical education programs and industry updates.

The annual Congress is the meeting place for stakeholders to reimagine how the industry delivers and pays for cancer care with a focus on improving outcomes for patients.

Since its founding, AON has expanded into 19 states and counting.

Drs. Seth Hollenbach, Nathan Littlejohn and Renee Warford commit to continue delivering high-quality, comprehensive, patient-first care to the community.

Susan Sabo-Wagner joins AON effective July 3.

Rahman joins AON with 15 years of experience in healthcare and oncology.

New oncology practice Florida Oncology & Hematology is now open to patients.

Dr. Ryan Olson joins AON effective June 26, 2023.

American Oncology Network expands into Texas with the opening of Lone Star Oncology.

AON physicians and leaders share their latest cancer findings with fellow thought leaders at the annual conference.